Reuters logo
BRIEF-Sigma Healthcare confirms underlying EBIT of $90 mln for FY2018
September 6, 2017 / 10:46 PM / 3 months ago

BRIEF-Sigma Healthcare confirms underlying EBIT of $90 mln for FY2018

Sept 7 (Reuters) - Sigma Healthcare Ltd:

* Sales revenue heavily impacted this year by pull back in sales of low margin hepatitis C medicines, exit of non-compliant branded customer group

* Confirms trading update provided on 11 August 2017 guiding to expected underlying EBIT of $90 million for FY2018

* A number of factors point to a more positive outlook for FY2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below